Absence of human T-cell lymphotropic virus type I and human foamy virus in thymoma

被引:0
|
作者
H Li
P J Loehrer
M Hisada
J Henley
D Whitby
E A Engels
机构
[1] Viral Epidemiology Branch,Division of Cancer Epidemiology and Genetics, Department of Health and Human Services
[2] National Cancer Institute,undefined
[3] 6120 Executive Blvd.,undefined
[4] EPS 8010,undefined
[5] Indiana University School of Medicine and Indiana University Cancer Center,undefined
[6] Viral Epidemiology Section,undefined
[7] AIDS Vaccine Program,undefined
[8] SAIC-Frederick,undefined
[9] National Cancer Institute-Frederick,undefined
来源
British Journal of Cancer | 2004年 / 90卷
关键词
thymoma; human T-cell lymphotropic virus type I (HTLV-I); human foamy virus; simian foamy virus; retrovirus;
D O I
暂无
中图分类号
学科分类号
摘要
The cause of thymoma, a rare malignancy of thymic epithelial cells, is unknown. Recent studies have reported the detection of DNA from human T-cell lymphotropic virus type I (HTLV-I) and human foamy virus (HFV) in small numbers of thymoma tumours, suggesting an aetiologic role for these retroviruses. In the present study, we evaluated 21 US thymoma patients and 20 patients with other cancers for evidence of infection with these viruses. We used the polymerase chain reaction to attempt to amplify viral DNA from tumour tissues, using primers from the pol and tax (HTLV-I) and gag and bel1 (HFV) regions. In these experiments, we did not detect HTLV-I or HFV DNA sequences in any thymoma or control tissues, despite adequate sensitivity of our assays (one HTLV-I copy per 25 000 cells, one HFV copy per 7500 cells). Additionally, none of 14 thymoma patients evaluated serologically for HTLV I/II infection was positive by enzyme-linked immunoassay (ELISA), while five (36%) had indeterminate Western blot reactivity. In comparison, one of 20 US blood donors was HTLV-I/II ELISA positive, and nine (45%) donors, including the ELISA-positive donor, had indeterminate Western blot reactivity. Western blot patterns varied across individuals and consisted mostly of weak reactivity. In conclusion, we did not find evidence for the presence of HTLV-I or HFV in US thymoma patients.
引用
收藏
页码:2181 / 2185
页数:4
相关论文
共 50 条
  • [1] Absence of human T-cell lymphotropic virus type 1 and human foamy virus in thymoma
    Li, H
    Loehrer, PJ
    Hisada, M
    Henley, J
    Whitby, D
    Engels, EA
    BRITISH JOURNAL OF CANCER, 2004, 90 (11) : 2181 - 2185
  • [2] HUMAN T-CELL LYMPHOTROPIC VIRUS-TYPE-I
    LARKIN, J
    SINNOTT, JT
    WEISS, J
    HOLT, DA
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1990, 11 (06): : 314 - 318
  • [3] Management of coinfection with human immunodeficiency virus and human T-Cell lymphotropic virus type I
    Nadler, JP
    Bach, MC
    Godofsky, E
    CLINICAL INFECTIOUS DISEASES, 1996, 23 (02) : 415 - 415
  • [4] Mechanisms of T-cell activation by human T-cell lymphotropic virus type I
    Höllsberg, P
    MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, 1999, 63 (02) : 308 - +
  • [5] Human T-cell lymphotropic virus type I and neurological diseases
    Masahiro Nagai
    Mitsuhiro Osame
    Journal of NeuroVirology, 2003, 9 : 228 - 235
  • [6] Is human T-cell lymphotropic virus type I really silent?
    Asquith, B
    Hanon, E
    Taylor, GP
    Bangham, CRM
    PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES, 2000, 355 (1400) : 1013 - 1019
  • [7] Human T-cell lymphotropic virus type I and neurological diseases
    Nagai, M
    Osame, M
    JOURNAL OF NEUROVIROLOGY, 2003, 9 (02) : 228 - 235
  • [8] ABSENCE OF HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-I COINFECTION IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED HEMOPHILIC MEN
    LAIRMORE, MD
    JASON, JM
    HARTLEY, TM
    KHABBAZ, RF
    DE, B
    EVATT, BL
    BLOOD, 1989, 74 (07) : 2596 - 2599
  • [9] Absence of human T-lymphotropic virus type I in Japanese patients with cutaneous T-cell lymphoma
    Kikuchi, A
    Nishikawa, T
    Ikeda, Y
    Yamaguchi, K
    BLOOD, 1997, 89 (05) : 1529 - 1532
  • [10] Is human T-cell lymphotropic virus type I more clever than human immunodeficiency virus type 1?
    Hrdy, DB
    CLINICAL INFECTIOUS DISEASES, 1999, 29 (05) : 1356 - 1356